Healthtech Startup Curelo Secures $100k Funding from IIM Ahmedabad's CIIE.CO

Founded in 2022 by Dr Arpit Jayswal, the platform offers a dedicated fleet of phlebotomists capable of collecting samples within 60 minutes of booking, ensuring efficient and timely services.

Gurugram-based healthtech startup Curelo, a digital healthcare marketplace and aggregator platform has raised $100k in funding from the Indian Institute of Management (IIM) Ahmedabad's CIIE.CO. 

The funding is to be used towards seamless booking of at-home blood sample collections for patients, ensuring swift access to their blood reports from a lab of their choice.

Founded in 2022 by Dr Arpit Jayswal, the platform offers a dedicated fleet of phlebotomists capable of collecting samples within 60 minutes of booking, ensuring efficient and timely services. 

It's a digital marketplace and aggregator platform for diagnostic labs in India. Further, Curelo enables patients to book lab tests from their preferred diagnostic lab at a time and place that suits them best. 

Once collected, the samples are swiftly delivered to the selected laboratory for processing. The platform also allows patients to discover labs based on test availability, pricing, and turnaround time.

In 10 months of its operations, Curelo said, it has partnered with over 1,350 labs and processed over 125,000 orders. 

The platform claims to be currently operating at a monthly run rate of INR 55 Lakh, experiencing a month-on-month growth of 30%. 

Curelo has ambitious plans to expand its services into radiology and blood bank aggregation in the near future. This funding injection from IIM Ahmedabad's CIIE.CO is anticipated to play a crucial role in propelling Curelo's vision of improving healthcare accessibility and patient convenience.

Earlier this month, Delhi-based data-driven wellness company Answer Genomics secured $500,000 in funding from Inflection Point Ventures. 

This funding infusion will fuel their mission to enhance well-being by delving into genomics, aiming to sequence 10,000 genomes in the next 12 months for personalised health insights.